Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 3,380.00
0.00 (0.00%)
At close: Dec 5, 2025
Access Bio Market Cap
Access Bio has a market cap or net worth of 118.89 billion as of December 5, 2025. Its market cap has decreased by -44.80% in one year.
Market Cap
118.89B
Enterprise Value
-231.97B
Revenue
54.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,380.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 118.89B, a decrease of -55.82%. That is a compound annual growth rate of -6.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 118.89B | -34.87% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | 784.36B | 1,061.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |